Cohen Veterans Network Celebrates 5th Anniversary of the Cohen Clinic in Mililani and Expands Mental Health Services for Hawaii’s Veteran and Military Communities

A new partnership with Endeavors will enhance the clinic’s reach and impact, building on care already provided to over 2,800 post-9/11 veterans, service members, and military families in Hawaii STAMFORD, Conn., Oct. 29, 2025 /PRNewswire/ — Cohen Veterans Network (CVN), a national not-for-profit integrated network of mental health clinics for post-9/11 veterans, service members and… Continue reading Cohen Veterans Network Celebrates 5th Anniversary of the Cohen Clinic in Mililani and Expands Mental Health Services for Hawaii’s Veteran and Military Communities

UNIVERSAL MUSIC GROUP AND UDIO ANNOUNCE UDIO’S FIRST STRATEGIC AGREEMENTS FOR NEW LICENSED AI MUSIC CREATION PLATFORM

Companies settle copyright infringement litigation and collaborate on groundbreaking new creative product suite SANTA MONICA, Calif., Oct. 30, 2025 /PRNewswire/ — Universal Music Group (UMG), the world leader in music-based entertainment, and Udio, an AI-powered music creation platform, today announced industry-first strategic agreements, under which the companies settled copyright infringement litigation and will collaborate on… Continue reading UNIVERSAL MUSIC GROUP AND UDIO ANNOUNCE UDIO’S FIRST STRATEGIC AGREEMENTS FOR NEW LICENSED AI MUSIC CREATION PLATFORM

LRN INVESTIGATION ALERT: Investigation Launched into Stride, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

SAN DIEGO, Oct. 29, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Stride, Inc. (NYSE: LRN) focused on whether Stride and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that… Continue reading LRN INVESTIGATION ALERT: Investigation Launched into Stride, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm

UNIVERSAL MUSIC GROUP AND UDIO ANNOUNCE UDIO’S FIRST STRATEGIC AGREEMENTS FOR NEW LICENSED AI MUSIC CREATION PLATFORM

Companies settle copyright infringement litigation and collaborate on groundbreaking new creative product suite SANTA MONICA, Calif., Oct. 29, 2025 /PRNewswire/ — Universal Music Group (UMG), the world leader in music-based entertainment, and Udio, an AI-powered music creation platform, today announced industry-first strategic agreements, under which the companies settled copyright infringement litigation and will collaborate on… Continue reading UNIVERSAL MUSIC GROUP AND UDIO ANNOUNCE UDIO’S FIRST STRATEGIC AGREEMENTS FOR NEW LICENSED AI MUSIC CREATION PLATFORM

Envista Reports Third Quarter 2025 Results

BREA, Calif., Oct. 29, 2025 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025. “This was another strong quarter for Envista, with core growth, adjusted EBITDA, and adjusted EPS all ahead of expectations,” said Paul Keel, CEO. “We delivered positive growth in all major businesses and once… Continue reading Envista Reports Third Quarter 2025 Results

Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development

-In head-to-head non-human primate (NHP) studies, average observed half-life of ASC36 was approximately 15 days, 3-fold longer than petrelintide, which supports once-monthly subcutaneous (SQ) dosing in humans. -ASC36 demonstrated approximately 91% greater relative body weight reduction compared to petrelintide in a head-to-head diet-induced obese (DIO) rat study. -ASC36 has excellent chemical and physical stability with… Continue reading Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development

Motiva – Results for the 3rd quarter of 2025

SÃO PAULO, Oct. 29, 2025 /PRNewswire/ — Highlights On July 04, 2025, the Amendment at SPVias was signed, resulting in the extension of the concession term by 73 days; On August 01, 2025, the Company signed an amendment to modernize the Motiva Pantanal contract; On September 26, 2025, the Amendment at ViaQuatro was signed, resulting in the extension… Continue reading Motiva – Results for the 3rd quarter of 2025

The China Fund, Inc. Announces Liquidating Distributions

BOSTON, Oct. 29, 2025 /PRNewswire/ — The China Fund, Inc. (NYSE: CHN) (the “Fund”) announced today that the Fund liquidated as planned on October 29, 2025, and the proportionate interests of stockholders in the assets of the Fund were determined as of that date. Prior to the opening of business on October 30, 2025, shares of… Continue reading The China Fund, Inc. Announces Liquidating Distributions

ZEISS and LG Chem join forces to strengthen the photopolymer supply chain for advanced optics

ZEISS and LG Chem established a strategic framework for industrial-scale photopolymer film supply in advanced optics. Partners co-develop photopolymer solutions for next-generation automotive holographic windshield displays, aiming for OEM production by 2029. The alliance strengthens supply chain resilience and supports the long-term growth of advanced holography and optical technologies across mobility and other sectors. JENA,… Continue reading ZEISS and LG Chem join forces to strengthen the photopolymer supply chain for advanced optics

MGM China Reports 2025 Third-Quarter Results

Record Third Quarter  Adjusted EBITDA Posted 20% Year-on-Year Growth HONG KONG, Oct. 29, 2025 /PRNewswire/ — MGM China Holdings Limited (“MGM China” or the “Company”; SEHK Stock Code: 2282) today announced the selected unaudited financial data of the Company and its subsidiaries (the “Group”) for the three months (the “Period”) and nine months ended September… Continue reading MGM China Reports 2025 Third-Quarter Results